Cerebral volume changes in multiple sclerosis patients treated with high-dose intravenous methylprednisolone

Multiple Sclerosis

Volumn 8, Issue 5, 2002, Pages 415-419

  Hoogervorst, E L J ^a   Polman, C H ^a   Barkhof, F ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

MRI and brain volume; MS; Steroids

Indexed keywords

BETA1A INTERFERON; METHYLPREDNISOLONE; PREDNISOLONE;

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; BRAIN TISSUE; BRAIN VENTRICLE; CLINICAL ARTICLE; DRUG EFFECT; DRUG MEGADOSE; FEMALE; FOLLOW UP; HUMAN; MULTIPLE SCLEROSIS; NEWBORN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; RELAPSE; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SHORT COURSE THERAPY; STATISTICAL SIGNIFICANCE; STEROID THERAPY; STUDENT T TEST;

ADULT; BRAIN; CEREBRAL VENTRICLES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; MALE; METHYLPREDNISOLONE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NEUROPROTECTIVE AGENTS; RETROSPECTIVE STUDIES;

EID: 0036783424     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/1352458502ms838oa     Document Type: Article

References (36)

1. The role of magnetic resonance techniques in understanding and managing multiple sclerosis
2. Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis
3. Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications
4. Quantitative assessment of MRI lesion load in multiple sclerosis. A comparison of conventional spin-echo with fast fluid-attenuated inversion recovery
5. The effect of gadolinium-enhancing lesions on whole brain atrophy in relapsing-remitting MS
6. Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group
7. A longitudinal study of brain atrophy in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)
8. Progressive cerebral atrophy in MS: A serial study using registered, volumetric MRI
9. Multiple sclerosis and corpus callosum atrophy: Relationship of MRI findings to clinical data
10. Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression
11. Spinal cord atrophy and disability in MS: A longitudinal study
12. Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss
13. Quantitative volumetric analysis of brain magnetic resonance imaging from patients with multiple sclerosis
14. Progressive cerebral atrophy in multiple sclerosis. A serial MRI study
15. Axonal transection in the lesions of multiple sclerosis
16. Immunopathology of multiple sclerosis: Report on an international meeting held at the Institute of Neurology of the University of Vienna
17. Brain atrophy as a surrogate marker in MS: Faster, simpler, better?
18. Brain atrophy in relapsing multiple sclerosis: Relationship to relapses, EDSS, and treatment with interferon beta-1a
19. Steroids and apparent cerebral atrophy on computed tomography scans
20. Apparent cerebral atrophy in patients on treatment with steroids
21. Reversible cerebral atrophy caused by corticotrophin
22. Cranial computed tomography (CCT) findings in children treated with ACTH and dexamethasone: First results
23. Cerebral atrophy in systemic lupus erythematosus: Ste
24. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
25. Defining the clinical course of multiple sclerosis: Results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis
26. Clinical trial of oral interferon beta-1a (R/Beneferon) in relapsing-remitting MS
27. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
28. Correlating MRI and clinical disease activity in multiple sclerosis: Relevance of hypointense lesions on short-TR/short-TE (T1-weighted) spin-echo images
29. Optimizing the association between disability and biological markers in MS
30. Relationship between brain atrophy and disability: An 8-year follow-up study of multiple sclerosis patients
31. Variability of brain atrophy in multiple sclerosis
32. Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: Longitudinal quantitative analysis
33. Detection of ventricular enlargement in patients at the earliest clinical stage of MS
34. A longitudinal study of ventricular volume in early relapsing-remitting multiple sclerosis
35. High dose steroids in acute relapses of multiple sclerosis: MRI evidence for a possible mechanism of therapeutic effect
36. High incidence of cortical atrophy of the cerebral and cerebellar hemispheres in Cushing's disease